Doctors in Colorado and Washington state will use scents like eucalyptus and lavender to treat children who lost their sense of smell to COVID-19.
After 9/11, the United States rapidly shifted resources to create a massive infrastructure to ferret out and combat terrorism while forgetting that terrorism of nature can be equally deadly.
A few scientists say that two small studies indicate that a decades-old antidepressant that costs $10 for a two-week course could be used to fight COVID.
So far, 72% of the inmates at the women's prison in Wilsonville have been vaccinated, barely enough to provide herd immunity on vaccinations alone.
There’s something for everyone with private health insurance in the American Rescue Plan Act, but determining the best way to benefit may be confusing.
“We need to take care of the problem everywhere to be able to take care of it anywhere,” says Dr. Mark Feinberg, president and CEO of the International AIDS Vaccine Initiative.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
Meanwhile, a committee hears from county commissioners who lament the complexity and confusion in the vaccination rollout and public messaging.
The low case counts in Oregon and Washington are laudable, but they create an unusual position: The states may have a more difficult time achieving herd immunity to COVID-19.
Public advocates say that more sustained funding will be needed over the next decade and beyond to address long-festering problems.